AVITA Medical, Inc. (RCEL) Misses Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts RCEL Hot Sheet
Join SI Premium – FREE
AVITA Medical, Inc. (NASDAQ: RCEL) reported Q2 EPS of ($0.38), $0.13 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $22.51 million.
For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Lockheed Martin wins $8.4B missile contract modification
- Obsidian Energy Increases Syndicated Credit Facility
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
